Frontlight ResearchEarly access
CompletedPhase 2/3
Insulin nasal spray to prevent delirium after cardiac surgery
Key facts
- Who runs it
- Radboud universitair medisch centrum Stichting
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2/3
- People taking part
- 30 people enrolled
- Started
- 29 Apr 2026
- Ended
- 10 Aug 2026
- Type of study
- Interventional
- Record updated
- 30 March 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age ≥65 years
- Planned surgical admission to the ICU of the Radboudumc following complex cardiac surgery with CPB. Complex surgery is defined as: combined procedures (e.g., multi-vessel CABG or single CABG + valve replace-ment/repair); or aortic surgery (ascending aorta, arch, or root) or repair of aortic dissection; or expected CPB duration ≥ 90 minutes, as estimated preoperatively
- Able to receive intranasal spray (no obstructive nasal pathology precluding administration)
- Informed consent from patient
Who cannot take part
- Delirium or dementia present at baseline
- Single-vessel CABG, single valve replacement/repair or off-pump cardiac surgery
- Known allergy/hypersensitivity to insulin or formulation excipients
- Contra-indication for nasal administration (severe nasal pathology, recent nasal/sinus sur-gery, active epistaxis, active rhinitis, obstruction of either one or both nostrils)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the feasibility, tolerability, and preliminary exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged ≥65 years after complex elective cardiac surgery with cardiopulmonary bypass.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Intranasal insulin for the prevention of delirium in ICU patients undergoing elective cardiac surgery: a randomized, double blind, placebo controlled pilot trial (INSPIRE)
- Record updated
- 30 March 2026